<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-231-11-90-95</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2967</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Сравнительный анализ особенностей анемии у пациентов с болезнью Крона и спондилоартритами</article-title><trans-title-group xml:lang="en"><trans-title>Comparative analysis of the features of anemia in patients with Crohn’s disease and spondyloarthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8463-2379</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Апаркина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Aparkina</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">alena437539@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8561-2214</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кашкина</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kashkina</surname><given-names>E. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Markova</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3463-7734</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ребров</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Rebrov</surname><given-names>A. P.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Саратовский государственный медицинский университет им. В.И. Разумовского» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saratov State Medical University named after V.I. Razumovsky (Razumovsky University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>11</month><year>2024</year></pub-date><volume>0</volume><issue>11</issue><fpage>90</fpage><lpage>95</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Апаркина А.В., Кашкина Е.И., Маркова А.А., Ребров А.П., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Апаркина А.В., Кашкина Е.И., Маркова А.А., Ребров А.П.</copyright-holder><copyright-holder xml:lang="en">Aparkina A.V., Kashkina E.I., Markova A.A., Rebrov A.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2967">https://www.nogr.org/jour/article/view/2967</self-uri><abstract><p>Цель исследования - провести сравнительный анализ особенностей анемии у пациентов с болезнью Крона и со спондилоартритами. Материалы и методы. В исследование включены 48 пациентов с болезнью Крона, верификация которой проводилась в соответствии с клиническими рекомендациями Российской гастроэнтерологической ассоциации (2018) и 62 пациента со спондилоартритами, отвечающих критериям аксиального спондилоартрита Assessment of Spondyloarthritis International Society (2009). Результаты. У пациентов с болезнью Крона анемия выявлена у 25 (52,1%) пациентов, из них у 80% зарегистрирована легкая анемия, у 20% - анемия средней степени. Анемия установлена у 22 (35,5%) пациентов со спондилоартритами. У всех пациентов со спондилоартритами выявлена анемия легкой степени. Уровень СРБ у пациентов с болезнью Крона при наличии анемии составила 17,8 [5,8; 35,8] мг/л, у пациентов без анемии - 6,4 [3,3; 12,8] мг/л (p=0,0006); среднее значение СОЭ у пациентов с анемией - 20,8 [12; 32] мм/ч, у пациентов без анемии - 8 [5;13] мм/ч (p=0,0000). Сывороточная концентрация CРБ у пациентов со спондилоартритами с анемией составила 16,4 [6,8; 34,2] мг/л, у пациентов без анемии - 8,2 [3,8; 15,2] мг/л (p=0,0007); среднее значение СОЭ у пациентов с анемией - 19,2 [11; 29] мм/ч, у пациентов без анемии - 9 [6;14] мм/ч (p=0,0000). Таким образом, у пациентов с болезнью Крона и со спондилоартритами с анемией показатели активности системного воспаления была достоверно выше. Учитывая показатели феррокинетики, у 4 (16%) пациентов с болезнью Крона и 6 (27,3%) пациентов со спондилоартритами выявлена анемия хронического заболевания, у 17 (68%) больных с болезнью Крона и 14 (63,6%) пациентов со спондилоартритами имелись признаки сочетания анемии хронического заболевания и железодефицитной анемии. Изолированная железодефицитная анемия выявлена у 4 (16%) пациентов с болезнью Крона и у 2 (9,1%) пациентов со спондилоартритами. Заключение. Анемия выявлена у половины пациентов с болезнью Крона и одной трети больных со спондилоартритами. Как для болезни Крона, так и для спондилоартритов наиболее характерной оказалась анемия смешанного генеза (анемия хронического заболевания и железодефицитная анемия).</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to conduct a comparative analysis of the features of anemia in patients with Crohn’s disease and with spondyloarthritis. Materials and methods. The study included 48 patients with Crohn’s disease, which was verified in accordance with the clinical recommendations of the Russian Gastroenterological Association (2018) and 62 patients with spondyloarthritis meeting the criteria of axial spondyloarthritis Assessment of Spondyloarthritis International Society (2009). Results. In patients with Crohn’s disease, anemia was detected in 25 (52.1%) patients, of whom 80% had mild anemia, and 20% had moderate anemia. Anemia was found in 22 (35.5%) patients with spondyloarthritis. Mild anemia was detected in all patients with spondyloarthritis. The level of CRP in patients with Crohn’s disease in the presence of anemia was 17.8 [5.8; 35.8] mg/l, in patients without anemia - 6.4 [3.3; 12.8] mg/l (p=0.0006); the average value of ESR in patients with anemia - 20.8 [12; 32] mm/h, in patients without anemia - 8 [5;13] mm/h (p=0.0000). The serum concentration of CRP in patients with spondyloarthritis with anemia was 16.4 [6.8; 34.2] mg/l, in patients without anemia - 8.2 [3.8; 15.2] mg/l (p=0.0007); the average value of ESR in patients with anemia - 19.2 [11; 29] mm/h, in patients without anemia - 9 [6;14] mm/h (p=0.0000). Thus, in patients with Crohn’s disease and with spondyloarthritis with anemia, the activity of systemic inflammation was significantly higher. Taking into account the indicators of ferrokinetics, 4 (16%) patients with Crohn’s disease and 6 (27.3%) patients with spondyloarthritis had anemia of chronic disease, 17 (68%) patients with Crohn’s disease and 14 (63.6%) patients with spondyloarthritis showed signs of a combination of anemia of chronic disease and iron deficiency anemia. Isolated iron deficiency anemia was detected in 4 (16%) patients with Crohn’s disease and in 2 (9.1%) patients with spondyloarthritis. Conclusion. Anemia was detected in half of patients with Crohn’s disease and one third of patients with spondyloarthritis. Anemia of mixed genesis (anemia of chronic disease and iron deficiency anemia) turned out to be the most characteristic for both Crohn’s disease and spondyloarthritis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>анемия</kwd><kwd>воспалительные заболевания кишечника</kwd><kwd>спондилоартриты</kwd><kwd>болезнь Крона</kwd></kwd-group><kwd-group xml:lang="en"><kwd>anemia</kwd><kwd>inflammatory bowel diseases</kwd><kwd>spondyloarthritis</kwd><kwd>Crohn’s disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis. 2000;6(2):142-150. doi: 10.1097/00054725-200005000-00013.</mixed-citation><mixed-citation xml:lang="en">Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis. 2000;6(2):142-150. doi: 10.1097/00054725-200005000-00013.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gisbert J.P., Gomollón F.Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103(5):1299-307. doi: 10.1111/j.1572-0241.2008.01846.x.</mixed-citation><mixed-citation xml:lang="en">Gisbert J.P., Gomollón F.Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103(5):1299-307. doi: 10.1111/j.1572-0241.2008.01846.x.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dignass A.U., Gasche C., Bettenworth D. et al.; European Crohn’s and Colitis Organisation [ECCO]. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211-222. doi: 10.1093/ecco-jcc/jju009.</mixed-citation><mixed-citation xml:lang="en">Dignass A.U., Gasche C., Bettenworth D. et al.; European Crohn’s and Colitis Organisation [ECCO]. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211-222. doi: 10.1093/ecco-jcc/jju009.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Antunes C.V., Hallack Neto A.E., Nascimento C.R. et al. Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology. Biomed Res Int. 2015;2015:728925. doi: 10.1155/2015/728925.</mixed-citation><mixed-citation xml:lang="en">Antunes C.V., Hallack Neto A.E., Nascimento C.R. et al. Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology. Biomed Res Int. 2015;2015:728925. doi: 10.1155/2015/728925.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kim K-J, Cho C-S. Anemia of chronic disease in ankylosing spondylitis: improvement following anti-TNF therapy. Arch Rheumatol. 2012;27(2):90-97. doi: 10.5606/tjr.2012.014.</mixed-citation><mixed-citation xml:lang="en">Kim K-J, Cho C-S. Anemia of chronic disease in ankylosing spondylitis: improvement following anti-TNF therapy. Arch Rheumatol. 2012;27(2):90-97. doi: 10.5606/tjr.2012.014.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Niccoli L., Nannini C., Cassarà E. et al. Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes.Int J Rheum Dis. 2012;15(1):56-61. doi: 10.1111/j.1756-185X.2011.01662.x.</mixed-citation><mixed-citation xml:lang="en">Niccoli L., Nannini C., Cassarà E. et al. Frequency of anemia of inflammation in patients with ankylosing spondylitis requiring anti-TNFα drugs and therapy-induced changes.Int J Rheum Dis. 2012;15(1):56-61. doi: 10.1111/j.1756-185X.2011.01662.x.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Revel-Vilk S., Tamary H., Broide E. et al. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur JPediatr. 2000, 159: 585-589. doi: 10.1007/s004310000491.</mixed-citation><mixed-citation xml:lang="en">Revel-Vilk S., Tamary H., Broide E. et al. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur JPediatr. 2000, 159: 585-589. doi: 10.1007/s004310000491.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Stein J., Hartmann F., Dignas A. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010, 7(11): 599-610. doi: 10.1038/nrgastro.2010.151.</mixed-citation><mixed-citation xml:lang="en">Stein J., Hartmann F., Dignas A. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010, 7(11): 599-610. doi: 10.1038/nrgastro.2010.151.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tsiolakidou G., Koutroubakis I.E. Stimulating erythropoiesis in inflammatory bowel disease associated anemia. World J Gastroenterol. 2007, 13: 4798-806. doi: 10.3748/wjg.v13.i36.4798.</mixed-citation><mixed-citation xml:lang="en">Tsiolakidou G., Koutroubakis I.E. Stimulating erythropoiesis in inflammatory bowel disease associated anemia. World J Gastroenterol. 2007, 13: 4798-806. doi: 10.3748/wjg.v13.i36.4798.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Safarova K.N., Dorogoykina K.D., Rebrov A.P. Is anemia a clinical marker of NSAIDs-induced upper gastrointestinal lesions in patientswith spondyloarthritis? Almanac of Clinical Medicine. 2019;47(5):410-8. (In Russ.) doi: 10.18786/2072-0505-2019-47-037.@@ Сафарова К.Н., Дорогойкина К.Д., Ребров А.П. Является ли анемия клиническим маркером НПВП-индуцированного поражения верхних отделов желудочно-кишечного тракта у пациентов со спондилоартритами? Альманах клинической медицины. 2019;47(5):410-8. doi: 10.18786/2072-0505-2019-47-037.</mixed-citation><mixed-citation xml:lang="en">Safarova K.N., Dorogoykina K.D., Rebrov A.P. Is anemia a clinical marker of NSAIDs-induced upper gastrointestinal lesions in patientswith spondyloarthritis? Almanac of Clinical Medicine. 2019;47(5):410-8. (In Russ.) doi: 10.18786/2072-0505-2019-47-037.@@ Сафарова К.Н., Дорогойкина К.Д., Ребров А.П. Является ли анемия клиническим маркером НПВП-индуцированного поражения верхних отделов желудочно-кишечного тракта у пациентов со спондилоартритами? Альманах клинической медицины. 2019;47(5):410-8. doi: 10.18786/2072-0505-2019-47-037.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss G., Schett G. Anaemia in inflammatory rheumatic diseases. Nat. Rev. Rheumatol. 2013;9(4):205-215. doi: 10.1038/nrrheum.2012.183.</mixed-citation><mixed-citation xml:lang="en">Weiss G., Schett G. Anaemia in inflammatory rheumatic diseases. Nat. Rev. Rheumatol. 2013;9(4):205-215. doi: 10.1038/nrrheum.2012.183.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rukavitsyn O.A. Anemia of chronic diseases: the important aspects of pathogenesis and treatment. Oncohematology. 2016;11(1):37-46. (In Russ.) doi: 10.17650/1818-8346-2016-11-1-37-46.@@ Рукавицын О.А. Анемия хронических заболеваний: отдельные аспекты патогенеза и пути коррекции. Онкогематология. 2016;11(1):37-46. doi: 10.17650/1818-8346-2016-11-1-37-46.</mixed-citation><mixed-citation xml:lang="en">Rukavitsyn O.A. Anemia of chronic diseases: the important aspects of pathogenesis and treatment. Oncohematology. 2016;11(1):37-46. (In Russ.) doi: 10.17650/1818-8346-2016-11-1-37-46.@@ Рукавицын О.А. Анемия хронических заболеваний: отдельные аспекты патогенеза и пути коррекции. Онкогематология. 2016;11(1):37-46. doi: 10.17650/1818-8346-2016-11-1-37-46.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Safarova K.N., Fedotov E.A., Rebrov A.P. Serum concentrations of interleukin-6 and tumor necrosisfactor alpha in patients with spondyloarthritis: a relationship between systemic inflammation and anemia. Bulletinof Siberian Medicine. 2022;21(2):115-121. (In Russ.) doi: 10.20538/1682-0363-2022-2-115-121.@@ Сафарова К.Н., Федотов Э.А., Ребров А.П. Сывороточная концентрация интерлейкина-6 и фактора некроза опухоли α у пациентов со спондилоартритами: связь между системным воспалением и анемией. Бюллетень сибирской медицины. 2022;21(2):115-121. doi: 10.20538/1682-0363-2022-2-115-121.</mixed-citation><mixed-citation xml:lang="en">Safarova K.N., Fedotov E.A., Rebrov A.P. Serum concentrations of interleukin-6 and tumor necrosisfactor alpha in patients with spondyloarthritis: a relationship between systemic inflammation and anemia. Bulletinof Siberian Medicine. 2022;21(2):115-121. (In Russ.) doi: 10.20538/1682-0363-2022-2-115-121.@@ Сафарова К.Н., Федотов Э.А., Ребров А.П. Сывороточная концентрация интерлейкина-6 и фактора некроза опухоли α у пациентов со спондилоартритами: связь между системным воспалением и анемией. Бюллетень сибирской медицины. 2022;21(2):115-121. doi: 10.20538/1682-0363-2022-2-115-121.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gubonina I.V., Shchukina O.B., Stuklov N.I. et al. Anemia in inflammatory bowel diseases: the approaches to its diagnosis, treatment and prevention. Almanac of Clinical Medicine. 2019;47(8):721-32. (In Russ.) doi: 10.18786/2072-0505-2019-47-078.@@ Губонина И.В., Щукина О.Б., Стуклов Н.И. и др. Анемия при воспалительных заболеваниях кишечника: подходы к диагностике, лечению и профилактике. Альманах клинической медицины. 2019;47(8):721-32. doi: 10.18786/2072-0505-2019-47-078.</mixed-citation><mixed-citation xml:lang="en">Gubonina I.V., Shchukina O.B., Stuklov N.I. et al. Anemia in inflammatory bowel diseases: the approaches to its diagnosis, treatment and prevention. Almanac of Clinical Medicine. 2019;47(8):721-32. (In Russ.) doi: 10.18786/2072-0505-2019-47-078.@@ Губонина И.В., Щукина О.Б., Стуклов Н.И. и др. Анемия при воспалительных заболеваниях кишечника: подходы к диагностике, лечению и профилактике. Альманах клинической медицины. 2019;47(8):721-32. doi: 10.18786/2072-0505-2019-47-078.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sieper J., Rudwaleit M., Baraliakos X. et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. AnnRheum Dis. 2009 Jun;68 Suppl 2: ii1-44. doi: 10.1136/ard.2008.104018.</mixed-citation><mixed-citation xml:lang="en">Sieper J., Rudwaleit M., Baraliakos X. et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. AnnRheum Dis. 2009 Jun;68 Suppl 2: ii1-44. doi: 10.1136/ard.2008.104018.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization (WHO). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. WHO; 2011. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf</mixed-citation><mixed-citation xml:lang="en">World Health Organization (WHO). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. WHO; 2011. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Muñoz M., Acheson A.G., Auerbach M. et al.International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017;72(2):233-247. doi: 10.1111/anae.13773.</mixed-citation><mixed-citation xml:lang="en">Muñoz M., Acheson A.G., Auerbach M. et al.International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017;72(2):233-247. doi: 10.1111/anae.13773.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
